You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Production of Ready-to-use DNA-based Diagnostics Kit for Dengue Virus Detection

    SBC: ACCESS BIO, INC.            Topic: ARMY03T28

    The first objective of Phase II is to validate the ready-to-use DNA-based dengue diagnostics kit under laboratory conditions using culture-derived dengue viruses as well as clinically confirmed dengue infected samples from different geographic origins. These prototype products will be developed for military and civilian settings which have ideal laboratory conditions. The second objective of Phase ...

    STTR Phase II 2004 Department of DefenseArmy
  2. Advanced Computational Algorithms for Simulating Weapon-Target Interaction

    SBC: ACTA, LLC            Topic: ARMY03T03

    This STTR project will develop and validate a robust, scalable computational capability for the simulation of weapon-target interactions of interest to the Army. The proposed algorithm is based on the FLIP (Fluid Implicit Particle) - MPM (Material Point Method) - MFM (Multiphase Flow Method) approach and CartaBlanca nonlinear solver environment developed at Los Alamos National Laboratory. CartaB ...

    STTR Phase II 2004 Department of DefenseArmy
  3. Novel A2A Adenosine Agonists in Vascular Protection

    SBC: ADENOSINE THERAPEUTICS, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): This is a phase II SBIR proposal to develop a new drug eluting stent to prevent restenosis. It is a 3-way collaboration between Adenosine Therapeutics, LLC, Setagon, Inc., and the University of Virginia. The work described here will be done at Adenosine Therapeutics (compound synthesis and pharmacokinetics) and the University of Virginia (Stent studies in pigs) ...

    STTR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  4. Method to Guarantee the Quality of Radiotherapy Planning

    SBC: ADVANCED PROCESS COMBINATORICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): This project will develop a package of planning products for radiation treatment that will introduce a measure of quality assurance now lacking, provide clinicians the opportunity to raise tumor dose, and expose the tradeoffs among the treatment constraints and objectives. The new approach based on mixed integer programming (MIP) will ensure that the dose distr ...

    STTR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  5. Improved Kit for Chemical Detection

    SBC: AGENTASE LLC            Topic: ARMY03T14

    Agentase has previously demonstrated that its technologies for enzyme polymerization can be used to detect nerve agent chemical weapons. That successful endeavor has resulted in a fielded product that is used by DoD, the US intelligence community, and emergency first responders. User feedback, while positive, suggests that an expansion of the sensor's detection capabilities beyond nerve agents w ...

    STTR Phase II 2004 Department of DefenseArmy
  6. Fluorescent Coated Filters for Detection of Biological Warfare Agent Microorganisms in Water

    SBC: ANALYTICAL BIOLOGICAL SERVICES, INC.            Topic: ARMY02T009

    Reliable and sensitive detection of biowarfare agents (BWAs) such as Bacillus anthracis, Yersinia pestis, Francisella tularensis, ricin, botulinum toxin, etc. is an important challenge for both military operations and domestic anti-terrorism efforts. We are proposing to develop a biomimetic polymer coating, containing receptors for BWA targets, that becomes fluorescent when exposed to samples con ...

    STTR Phase II 2004 Department of DefenseArmy
  7. Development of a Peptide Microchip System

    SBC: ATACTIC TECHNOLOGIES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The purpose of this proposal is to develop a protein assay technology that will parallel the newly developing oligonucleotide microarray techniques. We will develop a peptide system capable of performing high throughput real time measurements in parallel on a microfluidic chip. We will develop the chemistry to prepare these chips in Phase I and develop the s ...

    STTR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  8. Biocidal Textiles for Soldier Protection and Homeland Defense

    SBC: BIOSAFE, INC.            Topic: ARMY03T12

    Protection against biological warfare is a key military and civilian requirement strongly substantiated by recent events in the U.S. and around the world. This newly defined market has significant national defense implications. Protective clothing worn by United States military personnel can be contaminated by exposure to external bio-warfare agents or bacterial contamination from the skin. Bacte ...

    STTR Phase II 2004 Department of DefenseArmy
  9. Ultrasonic Registration of Knee Anatomy to MRI Images

    SBC: BLUE BELT TECHNOLOGIES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The proposed research will investigate the feasibility of using intra-operative ultrasound (US) images to non-invasively register the bone surfaces of the knee to preoperative magnetic resonance (MR) images. A surgical navigation system, KneeNav, is being developed by CASurgica for intraoperatively planning the proper location of ligament attachment sites and d ...

    STTR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  10. Pretest Probability Assessment for Pulmonary Embolism

    SBC: BREATHQUANT MEDICAL SYSTEMS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Pretest probability assessment (PTP) plays a pivotal role in the evaluation of pulmonary embolism (PE) in the emergency department (ED) and accurate PTP assessment can modify defensive test-ordering behavior by physicians. However, current methods of PTP assessment produce broad categories of risk that tend to over fit individual patients and seldom obviate tes ...

    STTR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government